Dasatinib enhances anti-leukemia efficacy of chimeric antigen receptor T cells by inhibiting cell differentiation and exhaustion

Overview of attention for article published in Journal of Hematology & Oncology, July 2021

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 37 Dimensions

Readers on

mendeley: 29 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 1 X post from an account with 192 followers.

Dasatinib enhances anti-leukemia efficacy of chimeric antigen receptor T cells by inhibiting cell differentiation and exhaustion. https://t.co/B9yzzy494s

22 Jul 2021

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.